Pnc Financial Services Group, Inc. Intellia Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 5,227 shares of NTLA stock, worth $49,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,227
Previous 16,860
69.0%
Holding current value
$49,708
Previous $346,000
82.66%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding NTLA
# of Institutions
327Shares Held
91.6MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$119 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$96.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$91.3 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$48.9 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$47.1 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $723M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...